Ardent Health, Inc. (NYSE:ARDT) Receives $14.21 Consensus Target Price from Analysts

Ardent Health, Inc. (NYSE:ARDT) has received an average rating of “Hold” from the fourteen research firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $14.2083.

Several equities analysts recently issued reports on ARDT shares. UBS Group raised their price target on Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Leerink Partners reduced their price target on Ardent Health from $16.00 to $15.00 and set an “outperform” rating on the stock in a research report on Friday, March 6th. Royal Bank Of Canada reduced their price target on Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, March 9th. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a research report on Friday, June 12th. Finally, Wall Street Zen upgraded Ardent Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th.

Ardent Health Price Performance

Shares of Ardent Health stock opened at $9.40 on Thursday. The company has a current ratio of 2.12, a quick ratio of 2.00 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $1.35 billion, a PE ratio of 9.89, a price-to-earnings-growth ratio of 2.07 and a beta of 0.84. The business’s 50-day moving average price is $9.48 and its 200-day moving average price is $9.14. Ardent Health has a 12 month low of $7.71 and a 12 month high of $15.48.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.18 by $0.10. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Sell-side analysts forecast that Ardent Health will post 1.11 EPS for the current fiscal year.

Insider Buying and Selling at Ardent Health

In other Ardent Health news, CFO Alfred Lumsdaine acquired 10,000 shares of the business’s stock in a transaction dated Friday, June 5th. The shares were purchased at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the transaction, the chief financial officer owned 329,183 shares in the company, valued at $2,900,102.23. This represents a 3.13% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.90% of the company’s stock.

Institutional Investors Weigh In On Ardent Health

Large investors have recently made changes to their positions in the business. Pier Capital LLC grew its position in shares of Ardent Health by 33.5% in the 3rd quarter. Pier Capital LLC now owns 580,620 shares of the company’s stock worth $7,693,000 after buying an additional 145,703 shares during the last quarter. Prescott Group Capital Management L.L.C. purchased a new position in shares of Ardent Health in the 4th quarter valued at approximately $1,077,000. LSV Asset Management purchased a new position in shares of Ardent Health in the 4th quarter valued at approximately $963,000. Denali Advisors LLC lifted its stake in shares of Ardent Health by 35.0% in the 4th quarter. Denali Advisors LLC now owns 249,450 shares of the company’s stock valued at $2,203,000 after purchasing an additional 64,650 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in shares of Ardent Health by 126.1% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,400 shares of the company’s stock valued at $92,000 after purchasing an additional 5,800 shares during the period.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.